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PRestrictive Annuloplasty for Ischemic Mitral
Regurgitation May Induce Functional Mitral Stenosis
Julien Magne, MSC, Mario Sénéchal, MD, FRCPC, Patrick Mathieu, MD, FRCPC,
Jean G. Dumesnil, MD, FRCPC, FACC, François Dagenais, MD, FRCPC,
Philippe Pibarot, DVM, PHD, FACC, FAHA
Québec City, Québec, Canada
Objectives The purpose of this study was to evaluate mitral valve hemodynamic performance and functional capacity in
patients with ischemic mitral regurgitation (MR) who underwent restrictive mitral valve annuloplasty (MVA).
Background Restrictive MVA combined with coronary artery bypass graft is the conventional approach for the surgical man-
agement of patients with ischemic MR. We hypothesized that the restriction of the mitral annulus could cause
an obstruction to antegrade mitral flow that may affect the patient’s functional capacity.
Methods A dobutamine stress echocardiography (DSE) and a 6-min walk test (6MWT) were performed in 24 patients with
ischemic MR 13  3 months after restrictive MVA and coronary artery bypass graft and in 20 control patients
with coronary artery disease matched for age, gender, and left ventricular ejection fraction.
Results None of the 24 MVA patients had significant MR after operation. Compared with control patients, MVA patients
had significantly (p  0.001) higher resting and stress peak gradients (rest: 13  4 mm Hg vs. 4  1 mm Hg;
DSE: 19  6 mm Hg vs. 6  3 mm Hg) and systolic pulmonary arterial pressures (PAP) (rest: 42  13 mm Hg
vs. 27  8 mm Hg; DSE: 58  12 mm Hg vs. 38  11 mm Hg) and lower (p  0.01) 6MWT distance (358 
95 m vs. 433  61 m). The resting peak mitral gradient correlated with systolic PAP (r  0.67; p  0.001)
and 6MWT distance (r  0.78; p  0.0001) in the MVA group.
Conclusions The results suggest that performing a restrictive MVA in patients with ischemic MR may create a functional mi-
tral stenosis. This hemodynamic sequel is associated with higher PAP and a worse functional capacity. (J Am
Coll Cardiol 2008;51:1692–701) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.11.082i
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5schemic mitral regurgitation (MR) is frequently observed
n patients with ischemic left ventricular (LV) dysfunction
nd is associated with poor outcomes (1,2). Restrictive
itral valve annuloplasty (MVA) combined with coronary
rtery bypass graft (CABG) is the conventional approach
or the surgical management of patients with ischemic MR
3). The size of the ring used for restrictive annuloplasty is
enerally selected by downsizing by 2 sizes the measured
ntertrigonal length. Despite this important restriction of
he anteroposterior mitral annulus distance, MR usually
ersists or recurs in more than 20% of patients after MVA
4), and the presence of residual MR adversely affects the
atient’s post-operative outcome (5).
rom the Laval Hospital Research Center/Québec Heart Institute, Faculty of
edicine, Laval University, Québec City, Québec, Canada. Supported by a grant
rom the Canadian Institutes of Health Research (MOP 67123), Ottawa, Ontario,
anada. Dr. Pibarot holds the Canada Research Chair in Valvular Heart Diseases,
anadian Institutes of Health Research, Ottawa, Ontario, Canada.C
Manuscript received May 2, 2007; revised manuscript received November 20, 2007,
ccepted November 26, 2007.The restriction of the anteroposterior annulus distance by
mplanting a rigid or semiflexible ring may reduce the mitral
alve effective orifice area (EOA) and the left atrial compli-
nce, which may cause high transmitral pressure gradients
nd pulmonary arterial pressure (PAP). We therefore
See page 1702
ypothesized that restrictive MVA in patients with ischemic
R could cause an obstruction to antegrade mitral flow that
ould, in turn, affect the patient’s functional capacity. The
bjective of the present study was to evaluate the resting and
xercise mitral valve hemodynamic performance and func-
ional capacity in patients who underwent restrictive MVA
nd had no evidence of persistent or recurrent MR after
peration.
ethods
atient population. From January 2004 to October 2006,
5 consecutive patients underwent restrictive MVA and
ABG for ischemic MR in our institution (Fig. 1). The
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April 29, 2008:1692–701 Surgery for Ischemic Mitral Regurgitationurgical protocol is described in our previous publication (5).
rom this cohort, we excluded patients with concomitant
rganic mitral valve lesions, mild aortic regurgitation or
tenosis, concomitant valve procedure, andmild persistent
r recurrent MR after MVA defined as a width of MR jet
ena contracta 3 mm. The final study group was com-
osed of 24 patients. These patients underwent a dobut-
mine stress echocardiography (DSE) followed by a 6-min
alk test (6MWT) 13  3 months after MVA. Nine of
hem also underwent an exercise stress echocardiography
ESE) that was performed within 30 days of the DSE. The
eta-blocker medication was withdrawn for at least 24 h before
SE, 6MWT, and ESE. The study protocol was approved by
he Institutional Review Board of Laval Hospital, and in-
ormed consent was obtained from all of the patients.
We also recruited a control group of 20 patients with
oronary artery disease who were matched with the MVA
atients for age, gender, and LV ejection fraction. Patients
ith more than mild MR, mild aortic regurgitation, or
ortic stenosis were excluded from the control group. These
ontrol patients underwent DSE and 6MWT using the
ame protocol as the MVA patients.
oppler-echocardiography at rest. Two-dimensional and
oppler transthoracic echocardiography examination was
rst performed at rest as previously described (6).
V GEOMETRY AND FUNCTION. The Doppler-echocardio-
raphic measurements included the LV and left artial (LA)
nd-diastolic and -systolic diameters, the LV ejection frac-
ion determined by the modified biplane Simpson method,
Figure 1 Description of the Patient Population
MR  mitral regurgitation; MVA  mitral valve annuloplasty.tnd the LV stroke volume mea-
ured in the LV outflow tract by
ulsed-wave Doppler.
ITRAL VALVE HEMODYNAMICS.
he mean transvalvular flow rate
as calculated by dividing the
eft ventricular outflow tract
LVOT) stroke volume by the
iastolic filling duration mea-
ured on the pulsed-wave Dopp-
er signal of the mitral flow ve-
ocity. The peak and mean
ransmitral pressure gradients
ere calculated using the modi-
ed Bernoulli equation. Mitral
alve EOA was determined by
he continuity equation using the
troke volume measured in the
VOT divided by the integral of
he mitral transvalvular velocity
uring diastole. The net atrioven-
ricular compliance (Cn) was cal-
ulated from the valve EOA and
itral flow E-wave downslope as previously described (6,7).
AP. Systolic PAP was calculated by adding the systolic
ight ventricular pressure derived from the tricuspid regur-
itation to the estimated right atrial pressure (8).
SE. The dobutamine infusion protocol was designed to
btain incremental increases in flow and a steady state at
ach level. It consisted of 5-min increments of 5 or 10
g/kg/min up to a maximum dosage of 40 g/kg/min. The
redetermined end points for terminating DSE were as
ollows: 1) maximal heart rate reached (defined as the
ormula: 220 age); 2) systolic blood pressure80 mm Hg
r 220 mm Hg or diastolic blood pressure 110 mm Hg;
) ischemia detected by electrocardiogram (ECG) (1 mm
orizontal or downsloping ST depression 0.08 s after the
-point compared with the resting ECG); 4) ventricular
rrhythmias (6 premature ventricular contractions per
inute or complex arrhythmia); 5) rapid new atrial arrhyth-
ias; and 6) symptoms.
Left ventricular geometry and function, peak and mean
ransmitral pressure gradients, valve EOA, Cn, and systolic
AP were measured at rest and at each stage of the DSE
rotocol.
SE. Nine of the MVA patients were submitted to a
aximum ramp semisupine bicycle exercise with the er-
ometer table tilted to 20° (patient in a mild left lateral
osition). The initial workload was set at 0 W, followed by
ontinuous increments of 10 to 25 W/min depending on the
atient’s physical condition. A 12-lead ECG was continu-
usly recorded, and blood pressure was measured every 2
in. The patients were encouraged to exercise until exhaus-
ion or the appearance of symptoms. The end points for
Abbreviations
and Acronyms
6MWT  6-min walk test
CABG  coronary artery
bypass graft
Cn  net atrioventricular
compliance
DSE  dobutamine stress
echocardiography
EOA  effective orifice
area
ESE  exercise stress
echocardiography
LV  left ventricular
LVOT  left ventricular
outflow tract
MVA  mitral valve
annuloplasty
PAP  pulmonary arterial
pressure
ROC  receiver-operating
characteristicerminating ESE were the same as those used for DSE. The
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Surgery for Ischemic Mitral Regurgitation April 29, 2008:1692–701oppler-echocardiographic measurements were performed
t rest in the semisupine position and at peak of exercise.
MWT. To evaluate the patient’s functional capacity, a
MWT was performed on the same day as the DSE
rotocol (9). The test was performed 2 times with a resting
eriod of 15 minutes between the 2 tests, and the average of
he distances achieved at these 2 consecutive tests was
ecorded.
tatistical analysis. Results are expressed as mean SD or
ercentages unless otherwise specified. Before analysis, nor-
ality distribution was tested using Kolmogorov-Smirnov
est. In the MVA group, differences between pre- and
ost-operative data and between rest and ESE data were
nalyzed using paired t test or signed rank test when
ormality test failed. The resting and DSE data were
nalyzed using 2-way analysis of variance for repeated
easures and a Tukey test to assess the effect of pharma-
ologic stress (DSE vs. rest) and group (MVA vs. control).
hen the normality test failed, the data were analyzed with
he use of a Mann-Whitney rank sum test. Linear regres-
ion analyses were used to evaluate the relationship between
chocardiographic parameters and 6MWT distance. For-
ard and backward multiple stepwise regression analyses
ere performed to identify independent predictors of
horter 6MWT distance. Age, gender, and variables with a
value of 0.05 on univariate analysis were entered in the
ultivariate model. Sensitivity, specificity, positive predic-
ive value, and negative predictive value for the prediction of
educed 6MWT distance defined as a distance  median
alue in the MVA group were determined for various cut-off
Pre- and Post-Operative Data of NYHA FunctionaEchocardiographic Variables in the 24 Patients
Table 1 Pre- and Post-Operative Data of NYHEchocardiographic Variables in the
Variables Pre-Ope
NYHA functional class
Class II
Class III
LV geometry
LVED diameter, mm
LVES diameter, mm
LVED indexed diameter, mm/m2
LVES indexed diameter, mm/m2
LV function
LV ejection fraction, %
LV stroke volume, ml/beat
Heart rate, beats/min
Cardiac output, l/min
Diastolic filling time, ms 4
Mean mitral flow rate, ml/s
Mitral valve hemodynamics
Mitral peak gradient, mm Hg
Mitral mean gradient, mm Hg
MR jet vena contracta width, mm*
Systolic pulmonary arterial pressure, mm Hg
Data are mean  SD, or number of patients (%). *That normality test
LV  left ventricular; LVED  left ventricular end-diastolic; LVES  left ven
annuloplasty; NS  nonsignificant difference (p  0.05); NYHA  New York Halues of the echocardiographic parameters using receiver-
perating characteristic (ROC) curves.
esults
re-operative and operative clinical data. Patients of the
VA group were operated for moderate to severe ischemic
R (vena contracta width 5.2  0.8 mm, range 4.0 to 7.0
m), and restrictive MVA was performed with the use of
Carpentier-Edwards Physio ring 24 mm in 8 patients
33%), 26 mm in 12 patients (50%), 28 mm in 3 patients
13%), and 30 mm in 1 patient (4%). All of these patients
nderwent CABG, with an average of 3  1.5 vessels
rafted.
As expected, there was no significant difference between
he MVA and control groups regarding gender distribution
16 [66%] male vs. 12 [60%] male; p  NS), mean age
65  8 [range 50 to 79] years vs. 66  11 [range 50 to 88]
ears; p  NS), body surface area (1.8  0.2 m2 vs. 1.7 
.2 m2; p  NS), and LV ejection fraction (43  11%
range 20% to 64%] vs. 45  10% [range 25% to 64%]; p 
S). The prevalence of comorbidities was also similar in
oth groups.
omparison of post-operative versus pre-operative data
n the MVA group. Mitral regurgitation severity and LV
eometry and function improved significantly after MVA
nd CABG (Table 1). On the other hand, resting mitral
eak and mean transmitral gradients and systolic PAP
ncreased significantly after surgery. There was also no
ss and of Doppler-ded in the MVA Group
nctional Class and of Doppler-
atients Included in the MVA Group
(n  24) Post-Operative (n  24) p Value
1) 17 (71) NS
9) 7 (29) NS
6 55 6 0.004
8 42 9 0.001
5 30 5 0.012
5 24 6 0.001
10 43 11 0.013
13 67 14 0.009
12 66 11 NS
1 4.6 1.2 0.001
152 476 143 NS
16 76 19 0.031
0.6 13 4 0.001
0.2 6 2 0.001
0.8 0.8 0.9 0.001
11 42 13 0.008l ClaInclu
A Fu
24 P
rative
17 (7
7 (2
60
47
33
26
37
57
66
3.9
93
64
4.5
1.5
5.2
31
failed.
tricular end-systolic; MR  mitral regurgitation; MVA  mitral valve
eart Association.
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April 29, 2008:1692–701 Surgery for Ischemic Mitral Regurgitationignificant improvement in the distribution of New York
eart Association functional class.
esting and stress echocardiographic data. The maxi-
um DSE dose (40 g/kg/min) was reached in 4 (17%) of
he 24 MVA patients, whereas DSE infusion was stopped at
lower dosage owing to chest discomfort in 4 (17%), new
apid atrial arrhythmias in 3 (13%), and ventricular arrhyth-
ias in 13 (54%). In the control group, the maximum dose
as reached in 12 (60%) of the 20 patients, and it was
topped at a lower dosage owing to the occurrence of
ymptoms or arrhythmias in 8 patients.
V GEOMETRY AND FUNCTION. Compared with the pa-
ients of the control group, those of the MVA group had
ignificantly larger LV end-diastolic (p  0.001) and
nd-systolic (p  0.001) diameters at rest and during DSE
Table 2). However, these differences were no longer
ignificant when the diameters were indexed for body
urface area. The differences in LV geometry between the 2
roups (Table 2) are likely related to the fact that, in
ontrast to control patients, MVA patients had a history of
oderate/severe ischemic MR and therefore of marked LV
ilation that was only partially reversed by surgery (Table 1).
There was a significant decrease in LV end-diastolic
iameter and a marked increase in heart rate, LV ejection
raction, LVOT stroke volume, cardiac output, and mean
itral flow rate during DSE in both control and MVA
atients (Table 2). Patients of the MVA group had similar
V ejection fraction but higher stroke volume at peak DSE
ompared with the patients of the control group. However,
Comparison of Resting and DSE Among thentrol Group (n  20) and the MVA Group (n 
Table 2 Comparison of Resting and DSE AmControl Group (n  20) and the MV
Variables
Con
Re
LV geometry
LVED diameter, mm 46
LVES diameter, mm 28
LVED indexed diameter, mm/m2 27
LVES indexed diameter, mm/m2 18
LV function
LV ejection fraction, % 45
Net atrioventricular compliance, ml/mm Hg 9.2
LV stroke volume, ml/beat 58
Heart rate, beats/min 76
Cardiac output, l/min 4.3
Diastolic filling time, ms 370
Mean mitral flow rate, ml/s 72
Mitral valve hemodynamics
Effective orifice area, cm2 2.9
Indexed effective orifice area, cm2/m2 1.7
Mitral peak gradient, mm Hg 4
Mitral mean gradient, mm Hg 2
MR jet vena contracta width, mm‡ 0.1
Systolic pulmonary arterial pressure, mm Hg 27
Data are mean  SD. *Significant difference (p  0.05) between rest
groups. ‡That normality test failed.
DSE  dobutamine stress echocardiography; other abbreviations as in Tabhey had lower peak heart rate and thus longer diastolic
lling time on DSE. Consequently, the maximum cardiac
utput and mean mitral flow rate reached during DSE were
imilar in both groups.
In the subset of 9 patients of the MVA group who also
nderwent ESE, there was no significant change in LV
imensions, whereas heart rate, LV ejection fraction, stroke
olume, cardiac output, and mean mitral flow rate increased
arkedly (Table 3).
ITRAL VALVE HEMODYNAMICS. Compared with the pa-
ients of the control group, those of the MVA group had
ignificantly lower mitral valve EOA and indexed EOA and
igher mitral gradients at rest and during DSE (Table 2).
mong the 24 MVA patients, 13 (54%) had a resting valve
OA 1.5 cm2, 15 (62.5%) had an indexed EOA 0.9
m2/m2, 10 (42%) had peak gradient 15 mm Hg, and 13
54%) had a mean gradient 5 mm Hg at rest. Therefore, a
arge proportion of the MVA patients had at least moderate
itral stenosis.
The vast majority of patients of the MVA group had a
arked increase in mitral mean and peak gradients during
SE and ESE (Fig. 2). This higher increase in mitral
radients observed during ESE is likely related to the higher
ncrease in heart rate and mean mitral flow rate achieved
uring ESE compared to DSE.
YSTOLIC PAP. Systolic PAP at rest was 42  13 mm Hg
nd increased up to 58  12 mm Hg during DSE (p 
.001) (Table 2) and up to 69  14 mm Hg during ESE
the
up (n  24)
roup (n  20) MVA Group (n  24)
DSE Rest DSE
39 6* 55 6† 50 9*†
27 8 42 9† 39 12†
21 7* 30 5 29 7*
12 8 24 6 22 7
55 13* 43 11 56 13*
6.2 4 3.3 1.2† 3.2 1.2
67 24* 67 14† 80 18*†
123 15* 66 11† 99 20*†
8.3 3.3* 4.6 1.2 7.8 1.6*
204 73* 476 143† 368 128*†
131 54* 76 19 121 42*
4.2 1.6* 1.5 0.3† 1.8 0.3*†
2.4 1* 0.8 0.2† 1.0 0.2*†
6 3* 13 4† 19 6*†
3 1* 6 2† 8 3*†
0 0† 0.8 0.9 0.6 0.9†
38 11* 42 13† 58 12*†
E data within the same group; †significant difference between the 224)
ong
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Surgery for Ischemic Mitral Regurgitation April 29, 2008:1692–701p  0.008) (Table 3) in the MVA group. Moreover, the
esting and DSE systolic PAPs of the MVA patients were
ignificantly higher than those of the control patients
Table 2).
In the MVA group, the prevalence of pulmonary arterial
ypertension defined as a resting systolic PAP 40 mm Hg
as 22% before MVA and 45% at the time of this
ost-operative study. In contrast, only 15% and 10% of the
ontrol patients had pulmonary hypertension at rest and
uring DSE, respectively.
When pooling rest, DSE, and ESE data, the systolic
AP of the MVA patients correlated well with mitral peak
radient (r  0.70; p  0.001) (Fig. 3) and mean gradient
r 0.62; p 0.001). Systolic PAP also correlated with Cn
r  0.44; p  0.0003). In contrast, there was no significant
orrelation between systolic PAP and these hemodynamic
arameters in the control group.
unctional capacity. The 6MWT was completed by 22
atients of the MVA group and 17 patients of the control
roup. The average 6MWT distance was 358 95 m in the
VA group, which was markedly lower (Fig. 4) than
he age and gender-predicted distance calculated using the
quation of Gibbons et al. (10) (492  59 m; p  0.001).
oreover, MVA patients had a significantly lower average
MWT distance compared with that of the control patients
433  61 m; p  0.01) despite similar age and gender-
oppler-Echocardiographic Data at Rest anduring ESE in Subset of 9 Patients With MVA
Table 3 Doppler-Echocardiographic Data at Rest andDuring ESE in a Subset of 9 Patients With MVA
Variables
Rest
(n  9)
ESE
(n  9) p Value
LV geometry
LVED diameter, mm 58 9 57 12 NS
LVES diameter, mm 43 15 41 11 NS
LVED indexed diameter, mm/m2 30 2 27 5 NS
LVES indexed diameter, mm/m2 21 6 20 5 NS
LV function
Ejection fraction, % 43 14 58 10 0.01
Net atriventricular compliance,
ml/mm Hg
3.4 1 2.4 1 NS
LV stroke volume, ml/beat 71 12 77 13 0.007
Heart rate, beats/min 68 7 114 23 0.004
Cardiac output, l/min 4.9 9.7 8.5 1.2 0.001
Diastolic filling time, ms 500 55 280 61 0.002
Mean mitral flow rate, ml/s 81 16 141 20 0.001
Mitral valve hemodynamics
Effective orifice area, cm2 1.5 0.4 1.7 0.3 NS
Indexed effective orifice area,
cm2/m2
0.80 0.2 0.90 0.2 0.08
Mitral peak gradient, mm Hg 12 4 24 7 0.004
Mitral mean gradient, mm Hg 6 3 14.4 5 0.03
MR jet vena contracta width, mm* 0.7 0.8 0.6 0.8 NS
Systolic pulmonary arterial
pressure, mm Hg
42 7 69 14 0.008
ata are mean  SD. *That normality test failed.
ESE  exercise stress echocardiography; other abbreviations as in Table 1.redicted distance in both groups (Fig. 4). Accordingly, the rercentage of predicted 6MWT distance was also signifi-
antly lower in the MVA group than in the control group
74  21% vs. 87  13%; p  0.036).
In the MVA group, the 6MWT distance correlated with
V end-systolic diameter (r  0.51; p  0.015), Cn (r 
.54, p  0.01), mitral peak gradient (rest: r  0.78; p 
.0001; DSE: r  0.58; p  0.004) (Fig. 5A), mean
radient (rest: r  0.65; p  0.001; DSE: r  0.26;
 NS), and systolic PAP (rest: r  0.68; p  0.001;
SE: r  0.60; p  0.006). Similar results were obtained
ith the percentage of age- and gender-predicted 6MWT
istance. In the control group, there was a trend for
orrelation between 6MWT distance and resting LV ejec-
ion fraction (r  0.49; p  0.09) and LA diameter (r 
0.54; p  0.06), whereas the percentage of age and
ender-predicted 6MWT distance correlated with LV end-
ystolic diameter (rest: r  0.73; p  0.005).
In forward and backward multiple stepwise regression
nalyses, the resting mitral peak gradient (r2  0.59; p 
.0003) and systolic PAP (r2  0.16; p  0.004) were
ndependently associated with reduced 6MWT distance
model r2  0.75) in the MVA group.
In ROC curve analysis (Table 4), the best predictors of
educed 6MWT distance (median value 350 m) in the
VA patients were mitral peak and mean gradient (area
nder the ROC curve  0.87 for both parameters). A mitral
eak gradient 13 mm Hg had the best performance for the
rediction of reduced 6MWT distance (sensitivity 92%, spec-
ficity 82%, positive predictive value 83%, negative predictive
alue 90%).
iscussion
he most important finding of this study is that a large
roportion (50%) of the patients who underwent success-
ul restrictive MVA in terms of correction of MR nonethe-
ess had a significant obstruction to antegrade mitral flow.
s a matter of fact, MVA patients had markedly higher
ransmitral gradients and PAP at rest and during DSE
ompared with control patients matched for age, gender,
nd LV ejection fraction. Moreover, the presence of a high
ost-operative transmitral pressure gradient was associated
ith reduced 6MWT distance in the MVA patients. These
ndings suggest that restrictive MVA may cause a func-
ional mitral stenosis and that this hemodynamic abnormal-
ty may negatively impact the patient’s functional capacity.
emodynamic outcome of restrictive MVA. Restrictive
VA aims at improving leaflet coaptation by correcting
osterior annular dilatation. Bolling et al. (11) were the first
o propose the use of undersized annuloplasty, which
onsists in implanting a prosthetic ring downsized by 1 or 2
izes (i.e., 2 or 4 mm) relative to the intertrigonal
istance. However, mild to moderate MR may persist or
ecur in more than 20% of patients after restrictive MVA
(
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ena contracta width 3 mm have worse clinical out-
omes (5).
Figure 2 Individual Changes in Mitral Peak and Mean Gradient
Stress Echocardiography in Patients With Mitral Valve
(A and B) Dobutamine stress echocardiographic (DSE) data. (C and D) Exercise s
r=0.70
P<0.001
Mitral Transvalvular Peak Gradient (mmHg)
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Figure 3 Systolic PAP Versus Mitral
Peak Transvalvular Gradient
Orange circles  resting data; brown circles  dobutamine stress echocardio-
graphic data; triangles  exercise stress echocardiographic data. PAP  pul-
monary arterial pressure.In the present study, we focused on the subset of patients
ho had no persistence or recurrence of clinically significant
R 1 year after operation (Fig. 1). Moreover, none of these
atients had a worsening of MR severity during DSE or
SE, thus excluding the presence of dynamic changes in
ing
uloplasty
chocardiographic (ESE) data.
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Figure 4 Predicted and Measured 6MWT Distances in
Mitral Valve Annuloplasty and Control Groups
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atients included in this study had a successful and persis-
ent correction of MR, a large proportion nonetheless
xhibited significant pulmonary hypertension and reduced
unctional capacity. Importantly, these hemodynamic and
unctional abnormalities can in large part be explained by
he presence of increased post-operative transmitral pressure
radients.
Our results thus suggest that the reduction of the mitral
nnulus area induced by restrictive MVA may often cause a
unctional mitral stenosis. Several mechanisms may explain
A
B
Figure 5 6MWT Distance Versus Resting
Mitral Peak Transvalvular Gradient
(A) Absolute 6MWT distance; (B) percentage of age
and gender-predicted 6MWT distance. 6MWT  6-min walk test.
Receiver-Operating Characteristic Curve AnalysiPrediction of Reduced 6-Min Walk Test Distanc
Table 4 Receiver-Operating Characteristic CPrediction of Reduced 6-Min Walk T
Variables Cut-Off Value
LVED diameter 70 mm
LV ejection fraction 52%
Atrioventricular compliance 3 ml/mm Hg
Mitral peak gradient 13 mm Hg
Mitral valve mean gradient 5 mm Hg
Systolic pulmonary artery pressure 48 mm HgAUC  area under the curve; NPV  negative predictive value; PPV  positivhis adverse hemodynamic consequence. First, the narrow-
ng of the mitral annulus area combined with the presence
f redundant mitral valve tissue within this narrowed orifice
ould contribute to reduce the mitral valve EOA available
or antegrade mitral blood flow. Second, this procedure may
educe the mobility of the posterior mitral valve leaflet.
ndeed, previous studies have shown that restrictive MVA
arkedly reduces the mobility of the posterior leaflet and
lters the valve closure in a single leaflet process. Third, the
mplantation of a rigid or semiflexible prosthetic ring may
onsiderably limit the expansion of the mitral annulus
uring diastole. In this regard, previous studies have dem-
nstrated that, as opposed to the aortic valve, the diastolic
xpansion of the mitral annulus is one of the key mecha-
isms involved in the opening of the mitral valve orifice
uring diastole (12).
Moreover, the constriction of the mitral annulus and the
imitation of its expansion during diastole may also reduce
he LA compliance. The relation between LA compliance
nd LA pressure is exponential and, in the presence of
oderate-severe valvular obstruction, the loss of the buff-
ring function caused by a reduction in LA compliance may
esult in an augmentation of the LA and PAPs. In the
resent study, atrioventricular compliance was lower in the
VA group than in the control group and it correlated with
oth PAP and 6MWT distance in the MVA group. Net
trioventricular compliance is, however, not only dependent
n LA compliance but also on LV compliance and could
herefore also be affected by a decrease in LV compliance. In
ontrast to what has been reported in previous series with
itral stenosis or mitral prosthesis-patient mismatch with
ormal LV function (6,7,13), impaired LV compliance may
lso have contributed to the increased PAP and reduced
MWT distance in the present series. Nonetheless, the fact
hat the systolic PAP correlated much better with peak
itral gradient than with Cn suggests that the impact of the
VA-induced valve obstruction on the pulmonary hemo-
ynamics was relatively more important than that of LV
ompliance.
linical impact of functional mitral stenosis caused by
estrictive MVA. The mitral valve hemodynamic abnor-
alities observed in the present series of patients after
estrictive MVA are similar to those observed in patients
ith mitral stenosis or mitral prosthesis-patient mismatch
the., <350 m) in the MVA Group
Analysis for the
istance (i.e., <350 m) in the MVA Group
C Sensitivity Specificity PPV NPV
0 73 70 71 72
6 100 50 67 100
0 64 60 61 62
7 91 82 83 90
7 73 91 89 77
4 100 60 71 100s fore (i.e
urve
est D
AU
0.7
0.6
0.5
0.8
0.8
0.7e predictive value; other abbreviations as in Table 1.
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50%) of the patients included in the present series had
tress mitral gradients and PAP similar to those observed in
atients with moderate to severe mitral stenosis under DSE
r ESE (Table 5) (15,16).
The stress hemodynamics of these patients also tended to
e worse compared with those reported in patients with
itral prosthetic valves (17,18). The level of systolic PAP
easured at DSE or ESE in the present series was also
arkedly higher than that observed in normal subjects
nder maximum exercise stress test (peak exercise systolic
AP 30 to 35 mm Hg) (19). Moreover, the stress
emodynamics of these patients also tended to be worse
ompared with those reported in patients with mitral
rosthetic valves (17,18).
It remains to be determined to what extent these hemo-
ynamic abnormalities have a negative impact on clinical
utcomes. By inference, it should, however, be noted that
he high post-operative transmitral gradients correlated
omparisons With the Results of Previous Studies in Patientsith Stenosis of Their Native Mitral Valve or W th Mitr l Pro thetic
Table 5 Comparisons With the Results of Previous Studies in PWith Stenosis of Their Native Mitral Valve or With Mitr
Author, Year (Ref. #) Group
No. of
Patients
Va
(
Present study Restrictive MVA (rest) 24 1.48
DSE 24 1.8
ESE 9 1.7
Schwammenthal et al.,
2000 (7)
Moderate-severe MS (rest) 20 1.19
Li et al., 2005 a (13) Severe MS (rest) 26 0.91
Li et al., 2005 b (6) MVR —
All patients (rest) 56 1.8
No PPM (rest) 16 2.3
Moderate-severe PPM (rest) 40 1.7
Magne et al., 2007 (14) MVR —
All patients (rest) 182 1.9
No PPM (rest) 41 2.0
Moderate PPM (rest) 124 1.9
Severe PPM (rest) 17 1.6
Reis et al., 2004 (15) Mitral stenosis —
No events (rest) 24 2.1
No events (DSE) 24
Events (rest) 29 1.0
Events (DSE) 29
Belgi et al., 2003 (16) MS asymptomatic 33 1.7
MS asymptomatic (DSE) 33
MS symptomatic 12 1.6
MS symptomatic (DSE) 12
Hobson et al., 2006 (17) MVR (rest) 23 1.67
MVR (DSE) 23 2.2
MVR (ESE) 23 1.8
Leavitt et al., 1991 (18) MS (rest) 12 1.4
MS (ESE) 12 1.6
MVR (rest) 11 2.5
MVR (ESE) 11 2.9
indicates that pressure half-time method was used to measure EOA.
DSE  dobutamine stress echocardiography; EOA  effective orifice area; ESE  exercise stre
nnuloplasty; MVR  mitral valve replacement; PAP  pulmonary arterial pressure; PPM  prostith a reduced 6MWT distance and that several studies aave shown that a reduced 6MWT distance is a powerful
redictor of morbidity and mortality in patients with heart
ailure (9). Moreover, in a recent study of patients with
itral prosthesis-patient mismatch and similar hemody-
amic abnormalities (Table 5), severe mismatch was asso-
iated with a 3.2-fold (95% confidence interval 1.5 to 6.8;
 0.003) increase in the risk of mortality after mitral valve
eplacement after adjustment for age, gender, and other
elevant risk factors (14).
The results of the present study therefore suggest that,
hen ischemic MR is treated by restrictive MVA, MR is
ften traded for mitral stenosis, which may obviate or
utweigh the benefits of this procedure on the hemody-
amic, functional, and clinical outcomes.
linical implications. In light of the relatively high post-
perative rates of persistent or recurrent MR recently
eported in the literature (4,5), one could be tempted to use
n even more restrictive annuloplasty with downsizing of
ore than 2 sizes. A recent study, however, suggested that
e
ts
osthetic Valve
A Valve IEOA
(cm2/m2)
Peak Gradient
(mm Hg)
Mean Gradient
(mm Hg)
Systolic PAP
(mm Hg)
0.82 0.2 13 4 6 2 42 13
1.0 0.2 19 6 8 3 58 12
0.9 0.2 24 7 14.4 5 69 14
— — 8.3 4 43 12
0.54 0.1 20 8 10 4 40 10
— — — —
1.1 0.3 11 4 4 2 42 10
1.4 0.1 8 2 3 1 34 8
1.0 0.2 12 4 4 2 46 8
— — — —
1.1 0.2 10 4 4 2 41 9
1.3 0.2 8 2 3 1 38 9
1.1 0.2 10 3 4 1 41 8
0.8 0.1 13 5 6 3 49 12
— — — —
— 12 5 6 3 —
— 20 9 11 5 —
— 20.5 8 12 4 —
— 40 10 24 7 —
* — 14 5 7 2 36 8
— 22 5 12 4 49 8
* — 20 6 11 4 44 10
— 33 12 22 9 65 12
— 11 5 4.3 1.7 —
— 13 5 7 3 —
— 19 6 10 3.5 —
— 17 11 9 7 41 19
— 28 10 17 8 70 32
— 12 5 5 2 27.5 8
— 18 7 8 2.5 39 15
cardiography; IEOA  indexed effective orifice area; MS  mitral stenosis; MVA  mitral valve
atient mismatch.Valv
atien
al Pr
lve EO
cm2)
 0.3
 0.3
 0.8
 0.4
 0.2
—
 0.4
 0.3
 0.3
—
 0.4
 0.3
 0.3
 0.3
—
 0.5
—
 0.2
—
 0.1
—
 0.1
—
 0.3
 0.5
 0.4
 0.4
 0.5
 0.6
 0.7more restrictive annuloplasty would likely further worsen
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estore adequate leaflet coaptation and MR correction (5).
oreover, the results of the present study suggest such a
trategy would further increase the risk and severity of
ost-operative mitral stenosis. It remains to be determined
f the newer prosthetic rings specifically designed to treat
schemic MR can improve the success rate for the correction
f MR without inducing mitral stenosis. Moreover, there
re at present many research efforts aimed at finding
rocedures that can improve LV geometry thus allowing the
reatment of ischemic MR on the basis of its causal
echanism (20). Further studies are needed to determine if
uch approaches will succeed in both correcting MR and
voiding mitral stenosis. Meanwhile, a potential alternative,
specially in the patients who are identified as being at high
isk for persistent or recurrent MR if treated by restrictive
VA (5), would probably be mitral valve replacement with
hordal sparing. If such a procedure is envisioned, it is,
owever, important to attempt to avoid prosthesis-patient
ismatch (14).
tudy limitations. The main limitation of this study is the
elatively small number of patients. The apparent lack of
ignificant association between PAP or 6MWT distance
nd some clinical or echocardiographic variables may be
elated to a type II error due to the small sample size.
onetheless, this limitation does not affect the validity of
he main results of this study, which is the demonstration
hat there is a high prevalence of mitral stenosis after
estrictive MVA and that there is a strong association
etween the transmitral pressure gradient and 6MWT
istance.
One could argue that the regression of pulmonary arterial
ypertension and the improvement of symptomatic status
ere incomplete at 1 year after MVA and that a longer-term
ollow-up would have shown better hemodynamic and
unctional results. However, previous studies have demon-
trated that the post-operative improvement in pulmonary
rterial hemodynamics and functional capacity essentially
ccur during the first year after mitral valve surgery (21).
In our experience, DSE is superior to ESE with respect to
he feasibility and reproducibility of the Doppler-
chocardiographic measurements of mitral valve hemody-
amics and PAP. On the other hand, ESE is a more
hysiological means to assess the behavior of LV function
nd mitral valve hemodynamics under stress conditions. In
his regard, one could argue that although the patients
elected in this study had no significant residual MR at rest,
dynamic appearance or worsening of MR during physical
xercise could have contributed to the impairment of func-
ional capacity. To address this issue, we randomly selected
subset of patients for ESE, and none of these patients had
dynamic occurrence or worsening of MR under exercise.
n fact, the data obtained in this subgroup further confirmed
hose obtained by DSE.onclusions
he present results show that restrictive MVA in patients
ith ischemic MR may create some degree of functional
itral stenosis. This hemodynamic sequela is associated
ith higher PAP and worse functional capacity. Further
tudies are needed, however, to determine to what extent
he mitral stenosis caused by restrictive MVA negatively
mpacts on other clinical outcomes. The present findings
lso provide an impetus toward the development of new
urgical procedures that would allow for efficient and long-
erm correction of ischemic MR without inducing mitral
tenosis.
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